Replies to post #212017 on Biotech Values

[Rocky3]

Schwab has a 3/1/17 report from Credit Suisse on FGEN. Its top-line estimates for for '18, '19', '20', '21, '22, '23, '24, and '25 are $263, $453, $759, $927, $887, $953, and $1023. It does break out per product or indicate percentage, etc.